semaglutide mc4r
Defeats Expected Weight Loss: Semaglutide Leads Trials
Tirzepatide’s stronger weight-loss effect in MC4R-deficient patients suggests that therapy can be tailored to genetic profiles, offering a more precise option than semaglutide alone. In practice, clinicians may soon choose drugs based on melanocortin-4 receptor status rather than a one-size-fits-all approach. Medical Disclaimer: This article is for informational purposes